Turning promising scientific discoveries into viable therapies often requires more than capital—it demands access to specialized facilities, experienced commercialization guidance, and the right partners. For Canadian biotech and life sciences companies navigating this complex path, the Centre for Drug Research and Development offers a collaborative environment designed to accelerate drug discovery and development. Delivered by adMare Bioinnovations, this national initiative connects companies with the expertise and infrastructure needed to move innovations closer to market.
Participants gain access to advanced research facilities in Vancouver, including shared lab and office spaces equipped for everything from analytical chemistry to in vivo pharmacology. Beyond physical infrastructure, the program emphasizes commercial insight, helping companies align scientific progress with real-world market opportunities. Businesses also benefit from being embedded in adMare’s broader life sciences ecosystem, which brings together researchers, industry leaders, and academic partners from across Canada to encourage collaboration and knowledge exchange.
Support through the Centre for Drug Research and Development varies by project and is structured to be non-repayable, making it particularly attractive for growth-stage SMEs and established enterprises alike. For life sciences companies looking to strengthen their R&D capabilities while building meaningful industry connections, learning more about how this program works can be an important next step in planning future innovation.
Was this guide helpful?
Rate it so we can improve our content.
Canada Proactive Disclosure Data
The Canadian government has funded over 400,000 businesses through 1.27 million grants and contributions. Check your eligibility in 60 seconds.